ESG Report 2021

The Group has formulated internal policies, pharmaceuticals correctly and reasonably. The stipulating that pharmaceutical labels and package Group will constantly monitor the use of the inserts must meet relevant requirements. pharmaceuticals, and will submit applications to the Pharmaceutical labels must itemise the drug name, National Medical Products Administration to amend ingredients, use of drug, directions and dosage, package inserts when necessary, so as to provide production date and other relevant information to let users with the best pharmaceutical information and users understand the usage and risks of the description. pharmaceuticals. Apart from pharmaceutical labels, At the same time, the Group has also set up the Group also formulates requirements for management procedures for plate making, printing, packaging labels on transportation, storage use and and acceptance of product labels, manuals, and active pharmaceutical ingredients. For example, such printed packaging materials. The Quality packaging labels must indicate the pharmaceutical Management Department will carry out acceptance name, number of packages, expiration date, storage and inspection work at every step, from the drafting, and transportation precautions and other necessary sample printing to printing of product labels, information to avoid incidents affecting drug quality manuals and packaging materials. This ensures that due to improper transportation and storage. Besides, all the materials will be put into the factories for use package inserts must contain details of the without errors, and minimises the possibility of pharmaceutical's directions, data and information product quality problems caused by printing errors. showing its safety, effectiveness and adverse drug reactions, so as to guide users to take the PRODUCT MARKETING AND PROMOTION Pharmaceutical sale is a key sector of the Group's of this, the Group regulates the distribution and business, while requirements for pharmaceutical promotion of pharmaceuticals in strict accordance promotion information are much higher and more with relevant laws and regulations. stringent than those of general commodities. In light The Group has formulated relevant systems that risk of bringing a negative reputation to the Group clearly enumerate the Group's advertising during the process. When selecting new dealers or requirements, application procedures of distributors, the Group will evaluate the company's advertisement and promotion data feed, precautions qualifications, storage conditions, business scope for use, etc. All pharmaceutical promotion permits and other criteria, and sign sales contracts information released by the Group is based on with qualified dealers or distributors. The storage scientific evidence, complies with the principles of conditions of dealers or distributors must strictly accuracy, objectivity, and completeness, and comply with the pharmaceutical storage conditions contains corresponding package inserts to clarify and requirements stated in the manuals for storage the correct medication methods. All these comply and use. At the same time, when quality problems with legal requirements. In order to ensure that the emerge, they must cooperate with the Group to Group's advertisements comply with relevant laws report and investigate the problem, collect evidence, and regulations, the samples of the advertising and carry out follow-up work to guarantee the materials must be submitted to the Group's Audit quality of products. The Group will establish archives and Legal Affairs Department for review before with the cooperating dealers and distributors to being released. completely record information, such as corporate qualification documents, signed contracts and The Group has established a pharmaceutical inventory turnover. The collected data will be used preparation sales distributor or distributor for analysing, evaluating and rating dealers and management system, which is implemented by the distributors to effectively manage product sales. Credit Risk Management Department to reduce the Realm Relevant Laws and Regulations and Guideline Product Marketing and Promotion Advertising Law of the People's Republic of China Standards for the Examination and Publication of Drug Advertisements Measures for the Examination of Drug Advertisements 48 Environmental, Social and Governance Report 2021 The United Laboratories International Holdings Limited

RkJQdWJsaXNoZXIy NTk2Nzg=